UroMaxi Flow^® – Helps maintain Prostate Health

Average quantities per tablet

*RDA: Recommended Daily Allowance (Directive 2008/100/CE)

**RDA Not Defined

*** RDA Not Applicable

Microcrystalline cellulose; L-Alanine; L-Glutamine; Beta-sitosterol;

Gamma-oryzanol; Nettle [Urtica dioica L., root d.e., standardized at 1% in beta-sitosterol, maltodextrins (may contain gluten)]; Glycine; Quercetin; Anti-binding agents: Talc and Magnesium stearate (vegetal origin); Vitamin E (D-alphatocopheryl acetate, soy by-products); Zinc citrate; Selenium (Selenium-enriched yeast); Calcium phosphate tribasic; Anti-binding agent: Colloidal silica (anhydrous); Pantothenic acid (Calcium D-Pantothenate); Vitamin B2 (Riboflavin); Folate (Pteroylmonoglutamic acid); Vitamin B12 (Cyanocobalamin).

It is recommended to take up to three tablets per day, one tablet about an hour before lunch and two tablets together, 1 hour before dinner. Swallow whole, do not chew.

If you are taking any prescribed medication or have any medical conditions always consult your doctor or pharmacist before taking vitamins or supplements. Keep out of sight and reach of young children. Do not exceed stated recommended intake. This food supplement is not intended to replace a well-balanced diet.

Do not take this supplement if you are hypersensitive to any of its constituents. It contains soy by-products.

If you are taking medicines, as for instance, to decrease platelet aggregation, anti-hypertensives or anti-clotting agents, consult you doctor or pharmacist before you start taking this supplement.

If you suffer from any deficiency (renal, hepatic etc), diabetes, clotting problems, hypertension or gastric ulcers, consult your doctor or pharmacist before you start taking this supplement.

This product is not recommended for women or children.

When taken at the recommended dosage Uro-Maxi Flow^® should not cause any unwanted side effects. However, in rare cases, this supplement may cause mild gastric upset such as gastric irritation, indigestion, flatulence, diarrhoea, nausea and headaches. These side effects are usually mild and disappear shortly after the supplement is discontinued.

The prostate gland is located below the bladder and is normally about the size of a walnut and produces the liquid component of semen (prostatic fluid) which is vital for effective reproduction. As men age, the prostate enlarges and in many cases this results in obstruction of the bladder and the production of bothersome symptoms.

In the UK alone 3.2 million men, over one third of men aged 50 ⁽¹⁾ and up to two thirds of men by the age of 60⁽²⁾, suffer from the symptoms of Benign Prostatic Hyperplasia (BPH).

Due to the location of the prostate, non-cancerous enlargement of the prostate (Benign Prostatic Hyperplasia – BPH) can result in squeezing of the urethra which can make it more difficult to pass urine. The symptoms of BPH which affect the lower urinary tract (bladder and urethra)are called ‘obstructive’ or ‘irritative’ symptoms and in addition a link has been highlighted⁽⁴⁾ between decreased erectile function and lower urinary tract symptoms (LUTS) associated BPH.

Obstructive symptoms are caused by the prostate putting pressure on the urethra, narrowing it and making it harder to for the urine to pass. Examples of obstructive symptoms are hesitancy (difficulty starting urination), Poor stream (weaker flow of urine, taking bladder longer to empty), dribbling/leakage (towards the end of flow, urine become a slow dribble or you experience leakage) and poor emptying (not being able to completely empty the bladder).

Irritative symptoms tend to be secondary to the obstructive symptoms as the bladder needs to work harder to function normally; the bladder thickens and reduces in capacity to hold urine. Examples of irritative symptoms are frequency (passing urine more often than normal), nocturia (getting up at night to urinate) and urgency (sudden and intense need to go to the toilet immediately).

These troublesome and unpleasant changes in normal urinary function do not just impair quality of life of patients and their families but also increase the risk of serious conditions such as acute urinary retention, hospitalisation and surgery. ⁽³⁾

View Product Factsheet

UroMaxi Flow^® – Natural BPH Supplement Factsheet (opens in new window)

Prescription drugs are available which either “shrink” the prostate or affect the flow of urine by acting on the prostate smooth muscle. As a result they can take some time to be effective. UroMaxi Flow^® has been formulated to have a rapid effect on the structures that control the flow of urine with a rapid corresponding time of action to improve problematic changes in urinary health.

Complementary and alternative products such as supplements have become increasingly popular as dietary health supplements for the treatment/improvement and prophylaxis of urological disorders and to improve general health and wellbeing.

UroMaxi Flow^® is a natural health supplement that has been formulated to assist specifically in the maintenance of prostate health and urinary tract function and is designed to be taken with prescription medicines or on their own. Each of the individual excipients were selected due to their potential role in the maintenance of a healthy prostate and urinary tract.

UroMaxi Flow® contains ingredients which have been shown clinically to beneficial in some patients to avoid or reduce the obstructive and irritative changes to urinary health. This natural daily supplement may benefit men with changes in urinary function predominantly suggestive of an obstructive condition.

UroMaxi Flow^® contains;

Glutamine: an antioxidant believed to assist in the stimulation of the immune system⁽⁵⁾

Glycine: an essential amino acid with anti-oxidant and anti-inflammatory actions⁽⁶⁾

Alanine: naturally present in prostatic fluid and in combination with glutamic acid and glycine, it is believed to relieve symptoms of prostatic infections^(7,8)

Beta-sitosterol: a naturally occurring phytosterol with anti-inflammatory, anti-proliferation and immune system stimulation properties. It has an established benefit in the relief of symptoms associated with BPH⁽⁹⁾

Gamma-oryzanol: a complex substance prepared from rice bran containing phytosterols and feruic acid with antioxidant properties

Quercetin: a naturally occurring flavoid with known anti-inflammatory, anti-proliferation and antioxidant properties which has been reported to improve symptoms related to prostatitis⁽¹⁰⁾

Nettle extract (Urtica Dioica): An anti-inflammatory effect in the prostate which has been reported to improve irritation and obstructive symptoms associated with BPH⁽¹¹⁾

Vitamins and minerals such as zinc, selenium, vitamin E, B2, B12 plus panthothenic acid and folate have been included into the formulation for beneficial effects on the prostate and urinary tract health.

1. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338:469–471

2. Arrighi HM, Metter EJ, Guess HA, Fozzard JL.Natural history of benign prostatic hyperplasia and risk of prostatectomy, the Baltimore Longitudinal Study of Aging. Urology 1991; 35 (Suppl): 4-8.

3. Speakman MJ, Kirby RS, Joyce A, Abrams P, Pocock R.Guideline for the primary care management of male lower urinary tract symptoms. BJU Int 2004; 93: 985–990

4. Schiff JD and Mulhall J. The link between LUTS and ED: clinical and basic scientific evidence. J Androl 2004; 25(4): 470-8

5. XCao Y, Feng Z, Hoos A, Klinbery VS. Glutamine enhances gut glutathione production. J Parenter Enteral Nutr 1998; 22:224-47

6. Wheeler MD, Ikejema K. Enomoto N, Stacklewitz RF, Seabra V, Zhong Z, Yin M, Schemmer P, Rose ML, Rusyn I, Bradford B, Thurman RG. Glycine: a new anti-inflammatory immunonutrient. Cell Mol Life Sci 1999; 56:843-56

7. Dumrau F. Benign prostatic hyperplasia. Amino acid therapy for symptomatic relief. Am J Geriatr 1962; 10: 426-30

8. Henry M, Feinblatt MD & Gant JC. Palliative treatment of benign prostatic hypertrophy. J Marine Med Assoc 1958; 46: 99-102

9. Berges RR, Windeler J, Trampish Hj, Senge J. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol study group. Lancet 1995; 345: 1529-32

10. Shoakes OA, Zeitlin Sl, Shaded A, Raifer A. Querceting in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo controlled-trial. Urology 1999; 54: 960-3

11. Safarinejad MR. Urtica dioica for treatment of benign prostatic hyperplasia: prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother 2005; 5:1-11